Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.

Igarashi T, Wynberg J, Srinivasan R, Becknell B, McCoy JP Jr, Takahashi Y, Suffredini DA, Linehan WM, Caligiuri MA, Childs RW.

Blood. 2004 Jul 1;104(1):170-7. Epub 2004 Mar 11.

2.

Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.

Hsu KC, Dupont B.

Semin Hematol. 2005 Apr;42(2):91-103. Review.

PMID:
15846575
3.

Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.

Ruggeri L, Mancusi A, Burchielli E, Perruccio K, Aversa F, Martelli MF, Velardi A.

Semin Cancer Biol. 2006 Oct;16(5):404-11. Epub 2006 Jul 8. Review.

PMID:
16916611
4.

Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.

Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A.

Cytotherapy. 2006;8(6):554-8. Review.

PMID:
17148031
5.

The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.

Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A.

Transpl Immunol. 2005 Aug;14(3-4):203-6. Review.

PMID:
15982564
6.

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.

Naumova E, Mihaylova A, Ivanova M, Mihailova S.

Cancer Immunol Immunother. 2007 Jan;56(1):95-100. Epub 2006 Mar 18. Review.

PMID:
16547704
7.

[KIRs on human NK cells and in relation with HLA class I antigen--review].

Dou LP, Da WM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Jun;14(3):627-30. Review. Chinese.

PMID:
16800958
8.

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.

Ruggeri L, Capanni M, Mancusi A, Urbani E, Perruccio K, Burchielli E, Tosti A, Topini F, Aversa F, Martelli MF, Velardi A.

Blood Cells Mol Dis. 2004 Nov-Dec;33(3):216-21. Review.

PMID:
15528134
9.

Role of KIRs and KIR ligands in hematopoietic transplantation.

Velardi A.

Curr Opin Immunol. 2008 Oct;20(5):581-7. doi: 10.1016/j.coi.2008.07.004. Epub 2008 Aug 23. Review.

PMID:
18675345
10.

Natural killer cell recognition of HLA class I molecules.

Brooks AG, Boyington JC, Sun PD.

Rev Immunogenet. 2000;2(3):433-48. Review.

PMID:
11256749
11.

Natural killer cells and their receptors.

Middleton D, Curran M, Maxwell L.

Transpl Immunol. 2002 Aug;10(2-3):147-64. Review.

PMID:
12216946
12.

Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?

Willemze R, Ruggeri A, Purtill D, Rodrigues CA, Gluckman E, Rocha V; Eurocord and of the European Group of Blood and Marrow Transplantation.

Best Pract Res Clin Haematol. 2010 Jun;23(2):283-90. doi: 10.1016/j.beha.2010.05.005. Review.

PMID:
20837340
13.

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA.

Blood. 2002 Sep 15;100(6):1935-47. Review.

14.

Killer immunoglobulin-like receptors.

Moretta L, Moretta A.

Curr Opin Immunol. 2004 Oct;16(5):626-33. Review.

PMID:
15342010
15.

The impact of variation at the KIR gene cluster on human disease.

Carrington M, Martin MP.

Curr Top Microbiol Immunol. 2006;298:225-57. Review.

PMID:
16329188
16.

Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, Renard V, Sandusky M, Stebbins CC, Wagtmann N, Watzl C.

Immunol Rev. 2001 Jun;181:223-33. Review.

PMID:
11513144
17.

Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.

Arina A, Murillo O, Dubrot J, Azpilikueta A, Alfaro C, Pérez-Gracia JL, Bendandi M, Palencia B, Hervás-Stubbs S, Melero I.

Expert Opin Biol Ther. 2007 May;7(5):599-615. Review.

PMID:
17477799
18.

The biology of natural killer cells and implications for therapy of human disease.

Chiorean EG, Miller JS.

J Hematother Stem Cell Res. 2001 Aug;10(4):451-63. Review.

PMID:
11522229
19.

[KIR and allogeneic hematopoietic cell transplantation - review].

Dong LJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Feb;12(1):108-14. Review. Chinese.

PMID:
14989784
20.

HLA-G and its KIR ligands in cancer--another enigma yet to be solved?

Urosevic M, Trojan A, Dummer R.

J Pathol. 2002 Mar;196(3):252-3. Review.

PMID:
11857486
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk